Cancer jab can eradicate entire tumours in patients, trial shows
A clinical trial for a new cancer drug called amivantamab has shown promising results, with the injection successfully eradicating tumors in some patients resistant to other treatments. The findings are being presented at the American Society of Clinical Oncology conference.
Why it matters
This represents a potential breakthrough in oncology, offering new hope for patients with limited treatment options for head, neck, and lung cancers.
Cancer jab can eradicate entire tumours in patients, trial shows | Cancer research | The Guardian
The article reports on scientific findings using objective medical terminology.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in